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Graphical abstract 
 
Abstract  
Three solvent based methods: spray drying (SD), electrospinning (ES) and air-assisted 
electrospinning (electroblowing; EB) were used to prepare solid dispersions of itraconazole 
and Eudragit E. Samples with the same API/polymer ratios were prepared in order to make 
the three technologies comparable. The structure and morphology of solid dispersions were 
identified by scanning electron microscopy and solid phase analytical methods such as, X-ray 
powder diffraction (XRPD), differential scanning calorimetry (DSC) and Raman chemical 
mapping. Moreover, the residual organic solvents of the solid products were determined by 
static headspace-gas chromatography/mass spectroscopy measurements and the wettability of 
samples was characterized by contact angle measurement. The pharmaceutical performance of 
the three dispersion type, evaluated by dissolution tests, proved to be very similar. According 
to XRPD and DSC analyses, made after the production, all the solid dispersions were free of 
any API crystal clusters but about 10 wt% drug crystallinity was observed after three months 
of storage in the case of the SD samples in contrast to the samples produced by ES and EB in 
which the polymer matrix preserved the API in amorphous state. 
 
 
Keywords: electrospinning, electroblowing, spray drying, Raman mapping, rapid dissolution, 
itraconazole 
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1. Introduction 
Most of the active pharmaceutical ingredients (APIs) are commercialized in tablets or 
capsules (Anselmo and Mitragotri, 2014), which are most accepted by patients. Development 
of cost-efficient technologies for these solid forms of human and animal pharmaceuticals is of 
great importance. 
The solubility of recently discovered APIs is often very poor (Macarron, 2006; 
Vasconcelos et al., 2007) in the gastrointestinal fluids, resulting in low oral bioavailability 
(Wong et al., 2006). Methods that are available to eliminate the solubility problem (Fahr and 
Liu, 2007; Sarode et al., 2014) are either costly or their industrial applicability is limited . 
The dissolution rate of APIs belonging to, the BCS II group can effectively be improved 
by use of salt forms with enhanced dissolution profiles (Agharkar et al., 1976), by 
solubilisation of drugs in co-solvents (Amin et al., 2004), by micellar solutions (Torchilin, 
2007), by formation of water-soluble complexes (Casella et al., 1998), by use of lipidic 
systems for the delivery of lipophilic drugs (Humberstone and Charman, 1997), by increasing 
the specific surface area of the API according to the Noyes–Whitney equation (Kawabata et 
al., 2011; Whitney and Noyes, 1897) or by forming solid dispersions of amorphous APIs 
(Sekiguchi et al., 1964; Simonelli et al., 1969; van Drooge et al., 2006). The combinations of 
the last two mentioned methods can be achieved by solvent based technologies, such as spray 
drying (SD) and electrospinning (ES). 
Although SD is widely used in pharmaceutical technology for preparing micro- and/or 
nanoparticles (Asker and Becker, 1966; Draheim et al., 2015; Fontana et al., 2014), it has 
some disadvantages. SD technologies are energy consuming, heat-sensitive APIs can be 
decomposed during the drying process, and furthermore, the separation and handling of the 
produced fine powder can cause difficulties (Broadhead et al., 1992; Cal and Sollohub, 2010). 
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ES is a facile and straightforward process for creating polymeric nanofibres, which can be 
exploited as carriers for developing a series of new drug delivery systems (DDS) (Ignatious et 
al., 2010; Kenawy et al., 2002; Nagy et al., 2010; Vigh et al., 2013; Yu et al., 2013). Using ES 
processes, not only the above-mentioned disadvantages can be eliminated, but also some new 
types of solid dispersions can be developed for poorly water-soluble drugs, such as third 
generation solid dispersions and structural solid dispersions (Yu et al., 2011, 2010). As for the 
scale-up of ES, recent efforts such as a high speed electrospinning (HSES) have shown the 
promising future (Nagy et al., 2015).  
Electroblowing (EB) is another scalable version of ES (Kim et al., 2003; Zhou et al., 
2009) but the use of this technology for producing DDS is still under development (Balogh et 
al., 2015). 
In this study, our aim was to compare the three solvent based technologies and their 
applicability for preparing Eudragit E based DDS containing iraconazole (ITR) as a model 
binary solid dispersion.  
ITR is a well-known broad-spectrum antifungal agent (Glasmacher and Prentice, 2006) 
belonging to BCS II (Wu and Benet, 2005), the solid dispersions of which have been 
published with Eudragit E matrix by several authors (Janssens et al., 2010; Jung et al., 1999; 
Six et al., 2003). In these works, the miscibility limit and phase separation of amorphous and 
crystalline ITR were investigated in melt extruded polymer systems in comparison with film 
casting and SD. The experimental miscibility limit (15% w/w when prepared by film casting 
or 27.5% w/w prepared by SD below the Tg of the polymer) was found to be strongly 
dependent on the manufacturing technology and higher value were achieved than expected 
based on theoretical study (7.07% w/w) (Janssens et al., 2010). Stability tests were not 
included in these experimental programs. 
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Our aim was to examine further details of the mentioned critical characteristics (phase 
separation and the influence of the solvent evaporation rate) of ITR-Eudragit E systems after 
producing their solid dispersions by methods and to investigate their stability after a three 
month-storage by several methods. 
 
2. Materials and methods 
2.1. Materials 
Crystalline ITR (with a purity of more than 99%) was obtained from Janssen 
Pharmaceutica (Beerse, Belgium). Eudragit® E was obtained from Evonik Industries 
(Darmstadt, Germany). Methanol, dichloromethane and concentrated HCl solution (it was 
diluted by purified water for dissolution media) were purchased from Merck Ltd. (Budapest, 
Hungary).  
2.2. Preparation methods 
ITR and Eudragit E were dissolved in a dichloromethane : methanol (4:1) solvent mixture 
and the resulting clear solutions were used for the preparation of solid samples. Spray-drying 
was performed with a Pro-Cep-T 4M8-TriX spray dryer (ProCept, Belgium). An infusion 
pump (Aitecs SEP-10S Plus syringe pump, Lithuania), a direct current power supplier (NT-35 
High Voltage DC Supply MA2000, Hungary) and spinnerets (in case of the ES a single fluid 
nozzle, while in the case of EB bi-fluids nozzle) were used to perform electrospinning and 
electroblowing. The process parameters are summarized in Table 1. The solid dispersions 
were stored for three months (90 days) at room temperature at 30% RH to examine their 
stability.  
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2.3. Scanning electron microscopy (SEM) 
The size and fine texture of the microparticles and fibres were investigated by a JEOL JSM 
6380LA (Tokyo, Japan) scanning electron microscope (acceleration voltage: 10 – 30 kV). 
Each specimen was fixed with conductive double-sided carbon adhesive tape and sputtered 
with gold – palladium alloy (using a JEOL 1200 instrument) in order to render it electrically 
conductive. 
2.4. Residual solvent measurement  
The amount of residual solvent in the samples was determined using a static headspace-gas 
chromatography-mass spectrometry (HS-GC/MS) method. A 20 – 100 mg sample was 
weighed into a 10 mL vial and 1.50 g of anhydrous sodium sulfate and 3 mL of distilled water 
were added before crimping. The sample was thermostated for 20 minutes at 80 °C and 
agitated at 600 rpm. A 0.5 mL sample was collected from the headspace with a 2.5 mL 
headspace syringe which was thermostated at 105 °C. The sample was injected to a 
split/splitless injector in split injection mode at a 20:1 split ratio. Injector temperature was set 
at 180 °C. An Agilent 7890 gas chromatograph was used with a RTX-VMS (20 m × 180 µm 
× 1 µm) column and separation was carried out isothermally at 40 °C with a constant 1 
mL/min flow of helium 5.0. The temperature of the transfer line, ion source and quadrupole 
were set at 250 °C, 230 °C, and 150 °C, respectively. The Agilent 5975C inert XL mass 
spectrometer was used in selected ion monitoring (SIM) mode with two SIM groups. Target 
ions were 29 (methanol) and 84 (dichloromethane); qualifier ions were 31 and 86, 
respectively; dwell time was 50 ms for each ions. External standard calibration was used. The 
stock solution for methanol was made with distilled water, for dichloromethane with 
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methanol, so two series of calibration solutions were prepared and measured. The calibration 
ranges were 20 – 1000 μg for methanol, and 0.3 – 100 μg for dichloromethane. 
2.5. X-ray powder diffraction (XRPD) measurement  
The pure itraconazole, Eudragit E and ITR-loaded microspheres and fibres were analysed 
with a PANalytical X’pert Pro X-ray MPD diffractometer (Almelo, The Netherlands). The 
measurements were under CuKα (λ=1.5406 Å), 40 kV and 30 mA as X-ray source with Kb 
(Ni) filter. The diffraction patterns were collected with 2θ ranging from 4 ° to 42 or 44 °. 
2.6. Differential scanning calorimetry (DSC) measurement and initial crystallinity 
determination 
Thermal analyses of solid dispersions were carried out using TA Instruments Q2000 
apparatus (New Castle, Delaware) in nitrogen atmosphere. The heating rate was 10 °C/min, 
heating scans were performed from 25 to 200 °C, and TA Instruments Universal Analysis 
2000 software was used for data analysis. The determination of the degree of crystallization 
before the DSC treatment needed special attention as the 20% or 40% API ratio of the 
samples started to crystallize during heating in the DSC apparatus. Therefore, the “initial 
crystallinity of the drug” (Six et al., 2002) was used for comparison, which means the sum of 
the integrals of the exothermic crystallization and endothermic melting peaks. When the API 
in a sample was amorphous, the sum was below the detection level (<3%). For the 
determination of initial crystallinity, the DSC curves were integrated from 110.0 to 175.0 °C 
(ranges of crystallization and melting for ITR), the resulted heat of fusion (ΔH) was corrected 
with the API concentration in the solid dispersions, and it was compared with the fusion 
enthalpy of pure crystalline ITR. Purified indium standard was used to calibrate the 
instrument. 
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2.7. Raman mapping 
Chemical mapping was carried out on electrospun, electroblown and spray-dried samples 
using LabRAM 300 micro-Raman spectrometer, manufactured by Horiba Jobin–Yvon 
(Longjumeau, France) equipped with an external diode laser source (785 nm, 400 mW) and 
an air cooled CCD detector. The spectra were recorded in the spectral range of 400-1835 cm-1 
and the high resolution maps were collected with an objective of ×100 magnification (laser 
spot size: ∼0.7 μm) and 1 μm step size. The acquired image consisted of 41 × 41 points 
(pixels), each spectrum was acquired for 10 s, and 2 spectra were averaged in each pixel. For 
the visualization of the API distribution in the polymer matrix, piece-wise linear base-line 
correction was applied on all spectra (using the same baseline points for all the maps points 
and the reference spectra). Afterwards, spectra were normalized to unit area and the 
component concentrations were estimated with the classical least squares (CLSs) method 
using the reference spectra of the pure polymer and amorphous ITR. LabSpec 5.41.15 
software was used for the spectral analyses and the visualization of chemical maps.  
2.8. Dissolution test 
In vitro drug dissolution tests were performed in 900 mL of 0.1 M HCl solution thermostated 
at 37±1 °C by means of a Pharma Test PTWS600 dissolution tester equipped with fully 
automated sampling system (Pharma Test, Hainburg, Germany), using the rotating basket 
apparatus (USP I) with 100 min-1 stirring speed. Previously ground fibrous samples and 
spray-dried microparticles containing 50 mg of the API were filled in the basket and the API 
concentration of the dissolution medium was determined by UV/VIS spectrophotometry 
(Hewlett-Packard - HP 8453 Diode Array UV/VIS spectrophotometer) at 254 nm based on a 
calibration line of standards with known concentration. 
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2.9. Contact angle measurements 
The wettability of SD, ES and EB samples was characterized by means of a contact angle 
goniometer (Dataphysics OCA15+; Germany) using the static sessile drop method. 5 µL of 
0.1 M HCl solution was dropped onto the surface of tablets compressed from the various 
samples (ITR preserved its amorphous form in the compressed tablets according to XRPD and 
DSC analyses.) at room temperature. An optical subsystem was used to capture the drop 
profile on tablets surface at 0 s and images were analysed using the ellipse fitting method 
following interface determination. 
3. Results and discussion 
3.1. Comparison of yields, productivity, morphology, and residual solvents 
The composition of solid dispersions, yields, content uniformity and productivity are 
summarized in table 2. The yields of solid products could be increased in all cases by 
increasing ITR concentration. The yield of SD, owing to the handling of the fine powder 
product, was somewhat less, but it is noted that it can be overcome in case of continuous high-
volume production. The deviation in the yields of the electrospun solid dispersions were in 
connection with the collection efficiency of the fibrous product. The same is true for the 
electroblown products. The productivity of ES could be improved effectively from 2 g/h to 
56.7 g/h (see table 2) by the use of an assisting airflow. Thus, ~28 times higher productivity 
could be achieved than by using the single fluid nozzle. The content uniformity of the samples 
was checked by UV/VIS spectrometry after dissolving accurately measured samples in 
ethanol. The data suggest that the API content of solid dispersions correspond to the 
theoretical values in all cases with high content uniformity. 
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The products prepared by the three (ES, EB and SD) continuous evaporation processes can be 
seen in figure 1. In terms of fibre-morphology, the electrospun samples were bead-free fibrous 
mats with diameters between 0.2 and 5 µm (figure 1a and b). The texture of the EB dispersion 
was also fibrous, but some beaded fibres with low diameter range were detected in case of the 
EB_20 (see figure 1c and d) owing probably to the reduced concentration of the solid 
materials in the solution. The SEM images of the SD samples show spherical products in the 
diameter rage of 1 to 30 µm (figure 1e and f).  
The solvent evaporation methods applied to prepare solid dispersions are critical in respect of 
the residual organic solvent content, which has to be limited to an acceptably low level. 
Therefore, the residual organic solvents of the solid dispersions were determined by HS/GC-
MS. The results are summarized in table 3. 
Considering the European Medicines Agency’s Guideline for Residual Solvents, these solid 
dispersions are fully compliant with the requirements. Residual methanol was below the 
calibration range in all the products, while the residual dichloromethane in the spray-dried 
sample (SD_40) was slightly beyond the lower limit of the calibration range, indicating a 
slight difference in the drying efficiency of the evaporation methods.  
 
3.2. Comparison of the solid dispersions by XRPD, DSC and Raman mapping  
XRPD analyses provided information about the physical state of ITR. The physical mixture at 
consisting of 20% w/w ITR and 80% polymer served as a reference (figure 2A g). The 
diffraction patterns suggest that ITR turned into amorphous form during all of the compared 
DDS-forming processes (see figure 2).  
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For getting further information about the state of ITR in these systems, the samples were 
examined by DSC as well. Four different exothermic and endothermic peaks appeared in the 
DSC curves of the crystallizable solid dispersions (figure 3, the DSC curve of SD_40 is 
characteristic of the transitions of all 40% w/w ITR loaded samples). The first peak belongs to 
the glass temperature (Tg) of the polymer and ITR, which includes the relaxation of the 
polymer matrix. The second endotermic signal at 89 °C corresponds to the transition from the 
chiral nematic mesophase to the isotropic liquid of ITR (Mt). The broad exotermic peak from 
110 °C to 155 °C corresponds to the cold crystallization of ITR, which follows the melting of 
the drug crystals at 169 °C (Six et al., 2002).  
The thermograms of the ES_20 and EB_20 samples did not show any peaks excepting 
the one caused by relaxation at the Tg transition (see table 4 and figure 4). The spray-dried 
sample (SD_20), which was amorphous according to the XRPD measurement (figure 2A e), 
shows exothermic and endothermic transition in its DSC curve suggesting some phase 
separation of amorphous matrix and amorphous drug, allowing cold crystallization and 
melting of ITR induced by heating. 
Van den Mooter et al. also observed the influence of drying kinetics on the phase 
structure. 
Raman microscopy can indicate specific interactions between components and 
determine their distribution in solid dispersions; therefore, such analyses were performed too. 
The Raman spectra of the ES, EB and SD samples could be very well approximated with the 
linear combinations of the reference spectra suggesting the absence of specific interactions 
between the ITR and polymer molecules, in accordance with earlier FT-IR results (Janssens et 
al., 2010). Clear evidence of phase separation was expected from the results of Raman 
mapping experiments. These maps are shown in figure 5.  
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The electrospun and electroblown samples (figure 5a, b, d, and e) did not show any 
inhomogeneity, while the spray-dried dispersions (figure 5c and f) were not perfectly 
homogeneous. The mixing level of polymer and ITR molecules remained high when 
electrostatic field was applied during the drying process. It corresponds to our recently 
published results (Sóti et al., 2015). The quantitative DSC data (table 4), in accordance with 
the XRPD diffraction patterns (figure 2), confirm that the samples were free of any crystal 
clusters after production. 
The three-month storage of solid dispersions did not cause a characteristic change in 
the diffraction patterns: the XRPD measurements repeated after 90 days still did not show 
crystalline phase in the solid dispersions above the detection limit of the method (figure 2). 
However, differences could be detected by the DSC analysis of spray dried samples within the 
range of 110 and 175 °C (table 4). The degree of initial crystallinity of dispersions determined 
according to DSC measurements showed about 10 wt% ITR crystalline part in both SD_20 
and SD_40, while the ES and EB products preserved the amorphous state of ITR (see table 4 
and figure 2). 
Considering the results of the solid phase analyses and the theoretical miscibility limit 
(cited in the introduction), the thermodynamically favoured phase separation of supersaturated 
solid dispersions was observed when the drying was proceed, in the case of spray drying, 
above the Tg of polymer, which facilitates the recrystallization of ITR. In turn, the ES and EB 
samples, which were prepared at room temperature and resulted in a homogenous distribution 
of ITR in the polymer matrix, had no tendency to crystallize at the storage conditions. (When 
the API/matrix ratio was raised from 1:4 to 2:3, the appearance of the mesophase transition 
and cold crystallization in DSC suggested some phase separation even for the ES and EB 
samples, but it happened only at submicronic level according to the homogeneous Raman 
maps.). 
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3.3. Dissolution results  
The pharmaceutical performance of the dispersions was evaluated by measuring their 
dissolution properties in 0.1 M HCl (figure 6). The dissolution tests were performed for 
comparison on the physical mixtures of the crystalline drug and the polymer. The dissolution 
was 100% in the case of each solid dispersion sample after 40 min, which is a dramatic 
increase compared to the physical mixture, which can be ascribed to the fine solid dispersion 
of the mostly amorphous drug in the highly soluble tertiary amine type carrier. Moreover, by 
decreasing the API/matrix ratio (from 2:3 to 1:4) the total dissolution time of ITR could be 
reduced from 40 to 10 min. Based on the results, all the three solvent-based technologies are 
similarly applicable for improving the dissolution rate of ITR. The phase separation of the 
matrix and ITR, shown by DSC and Raman results, had no effect on the dissolution profile. 
During the applied storage period the solid dispersions preserved the improved dissolution 
rate and we observed no changes in the drug release. Even the spray dried dispersions 
behaved the same way in spite of their partial recrystallization according to DSC. In fact only 
the amorphous state is maintained even after the phase separation during the process, as 
detected by the Raman mapping, and only longer storage or DSC heat treatment induced the 
recrystallization. 
For the interpretation of the observed differences between the dissolution profiles of the 
samples with different ITR content, the wettability of the samples was characterized by 
contact angle measurements. It was observed that the contact angles of the samples containing 
40% w/w ITR are significantly higher than those of the 20% w/w ITR contained samples. The 
results in figure 7 are given for EB samples, which were the same for ES and SD within the 
margin of error. When the ITR concentration was increased in the dispersions, the DDS 
became more hydrophobic, thereby reducing the wettability of samples, which caused a 
somewhat slower drug release.  
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4. Conclusions 
In this study, the electrospinning, electroblowing (air-assisted electrospinning) and spray-
drying methods were compared for preparing itraconazol and Eudragit E solid dispersions. 
The productivity of ES could be improved effectively by the use of assisted airflow without 
any significant change in the drug dissolution profile, physical state and distribution of the 
API in the polymer matrix at all of the applied API/matrix ratios. The dissolution rate of ITR 
could be enhanced significantly compared to the physical mixtures of raw materials by all of 
the studied solvent evaporation methods. Although the XRPD analyses did not show any 
differences between the products of various drying processes, DSC and Raman mapping 
suggested phase separation of amorphous polymer and amorphous API in the case of the 
spray dried samples providing chance for recrystallization during the applied three-month 
storage period. The samples preserved the improved dissolution rate of ITR during the storage 
period in spite of partial segregation in the samples containing 40% ITR, and just started 
crystallization of the spray dried solid dispersions. The results indicated differences in the 
distribution of amorphous API in the supersaturated matrix leading to different probabilities 
of crystallization during storage. It highlights the importance of solvent evaporation rate when 
kinetically stabile (but thermodynamically unstable) solid dispersions are prepared. These 
results point out also the capability of high resolution Raman mapping to determine subtle 
differences in the structure of amorphous solid dispersions (ASD) and indicate how the 
properties of ASD depend on the manufacturing and processing conditions. The 28-fold 
higher productivity of the electroblowing process compared to the related electrospinning 
method is promising for further improvement. By multiplying the spinnerets, the total output 
can be further increased. The pharmaceutical performance of EB product proved to be 
equivalent with the ES counterpart. 
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 Figure captions 
 
Figure 1 SEM images of samples: ES_20 (a); ES_40 (b); EB_20 (c); EB_40 (d); SD_20 (e) 
and SD_40 (f); scale bar: 10 µm 
 
Figure 2 X-ray powder diffractions pattern of solid dispersions A: ES_20 0 day (a); ES_20 90 
days (b); EB_20 0 day (c); EB_20 90 days (d); SD_20 0 day (e); SD_20 90 days (f); physical 
mixture of 20 w/w% ITR and polymer (g); B: ES_40 0 day (a); ES_40 90 days (b); EB_40 0 
day (c); EB_40 90 days (d); SD_40 0 day (e) and SD_40 90 days (f) 
 
Figure 3 Measured DSC curves of Eudragit E (a), crystalline ITR (b), and SD_40 (c) 
 
Figure 4 DSC curves of ES_20 (a); EB_20 (b); SD_20 (c) directly after production, and of 
the physical mixture of 20% w/w ITR and polymer (d). The arrows indicate the ITR melting 
endotherms. 
 
Figure 5 Raman maps of solid dispersions directly after production: ES_20 (a); EB_20 (b); 
SD_20 (c); ES_40 (d); EB_40 (e) and SD_40 (f). The arrows indicate the inhomogeneity of 
ITR distribution (the scales indicate the spectral concentrations of amorphous ITR). 
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Figure 6 Dissolution profiles of solid dispersions directly after the production (0) and 
following a three-month storage (90). The error bars indicate ± S.D. (n = 3). 
 
Figure 7 Wettability of EB samples containing 20% w/w (a) and 40% w/w (b) ITR (repeated 
measurement; n = 3) 
 
 
 
Table 1 Applied technologies and parameters 
 
Technology 
parameters 
Technologies 
ES EB SD 
Polymer 
concentration 
(wt%) 
12 17 2.4 
Solution feeding 
rate (mL/g) 10 200 150 
Nozzle-to-collector 
distance (m) 0.25 0.30 - 
Applied voltage 
(kV) 30 50 - 
Nozzle internal 
diameter (mm) 0.75 0.75 0.4 
Spray air pressure 
(bar) - 1 0.5 
Drying air flow 
rate (m3/min) - - 0.3 
Drying air 
temperature (°C) 25 25 70 
Cooling air flow 
rate (m3/min) - - 0.27 
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Table 2 Yields, composition, and content uniformity of ITR loaded solid dispersions prepared 
by various technologies 
Sample code Technology 
Nominal 
concentration of 
ITR in the solid 
dispersions 
(w/w%) 
Yieldsa 
(%) 
Productivity 
(g/h) 
ITR content in 
solid 
dispersions 
(%)b 
Cryst. ITR - 100 - - 99.8 ± 0.5 
ES_20 ES 20 71 1.5 100.2 ± 0.7 
ES_40 ES 40 73 2 100.8 ± 0.6 
EB_20 EB 20 62 42.5 100.5 ± 0.9 
EB_40 EB 40 66 56.7 100.4 ± 0.4 
SD_20 SD 20 51 4.5 100.0 ± 0.7 
SD_40 SD 40 65 9 100.7 ± 0.8 
 
a The yields were determined based on outcome of the solid product related to the solid 
starting materials. b Mean ± S.D. for three repeated measurement. 
 
 
 
 
Table 3 The concentration of residual solvents in solid dispersions 
Sample c (μg/g, ppm) methanol 
c (μg/g, ppm) 
dichloromethane 
LLOQa 1000 15 
Cryst. ITR <1000 <15 
ES_20 <1000 <15 
ES_40 <1000 <15 
EB_20 <1000 <15 
EB_40 <1000 <15 
SD_20 <1000 <15 
SD_40 <1000 21 
LRSb 3000 600 
 
 
a LLOQ: lower limit of quantification, b LRS: limit of residual solvent (Guideline for Residual 
Solvents, European Medicines Agency 2010) 
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Table 4 Initial crystallinity of ITR in the polymer matrix (90 indicates the storage days) 
note: ΔH110-175 means the sum of heat induced crystallization and melting peaks of ITR in the 
samples (<3% means that the difference of the two values is below the detection level). 
*Related to the ITR content of samples. 
 
Entry 
Mesophase transition Calculated initial crystallinity of ITR 
Temperature 
(°C) 
ΔHMt 
(J/g) 
ΔH110-175 
(J/g) 
w/w%* 
Cryst. ITR - - 94.05 100 
ES_20 - <0.06 <0.94 <3 
EB_20 - <0.06 <0.94 <3 
SD_20 87.40 0.07 <0.94 <3 
ES_40 89.03 0.27 <0.94 <3 
EB_40 88.95 0.25 <0.94 <3 
SD_40 89.45 0.36 <0.94 <3 
ES_20_90 - <0.06 <0.94 <3 
EB_20_90 - <0.06 <0.94 <3 
SD_20_90 88.43 0.06 1.69 9 
ES_40_90 89.12 0.36 <0.94 <3 
EB_40_90 89.38 0.16 <0.94 <3 
SD_40_90 89.54 0.37 3.86 10 
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